Dark Side of Weight Loss/Diabetes Drugs Ozempic & Mounjaro! [1ZFQn0SkY]

Dark Side of Weight Loss/Diabetes Drugs Ozempic & Mounjaro! [1ZFQn0SkY]

If you're in the loop about obesity weight loss drugs like Ozempic, Mounjaro, Wegovy, and Zepbound, then buckle up because we're diving deep into the less-discussed side of these weight warriors. HolisticMD is here to spill the beans on what your doctors might not be fully aware of. Back in January 2023, semaglutide, a GLP-1 receptor agonist, was given the green light for weight regulation, heralding a new era in obesity therapy. While these agents like semaglutide and liraglutide mimic intestinal hormones and primarily cause gastrointestinal issues, recent findings have shed light on some rare and severe side effects you should know about. A JAMA study dropped a bomb, revealing a ninefold increase in pancreatitis risk linked to GLP-1 receptor agonists. Brace yourselves for more unsettling stats: four times more intestinal obstructions and over three times more cases of gastroparesis. The absolute risks, however, are less than 1% per year of use, offering a sliver of reassurance. European Medicines Agency raised eyebrows with reports of depression and thoughts of self-harm in patients on liraglutide or semaglutide. About 150 cases are under investigation, with parallels drawn to similar issues seen with other weight loss medications. Caution is advised for those with a history of mood concerns. The weight loss benefits of GLP-1 receptor agonists might come with a lifelong commitment. However, the long-term side effects and complications, especially for weight reduction, remain uncertain. Studies in mice hint at an increased risk of thyroid carcinomas, but the human scenario is a waiting game. If you or your family has a history of medullary thyroid carcinoma, steer clear of dulaglutide, liraglutide, semaglutide, and tirzepatide. On the flip side, for those ready to level up with tirzepatide or retatrutide (GLP-1/GIP/glucagon), be prepared for potential gastrointestinal events. Timestamp: 0:00 Introduction 0:57 Weight Loss Drugs 1:50 Studies About GLP-1 Side Effects 5:26 Effects On Mental Health 7:05 Conclusions CHECK sugarmds.com for pure health supplements. Who is Dr. Ergin? Dr. Ahmet Ergin is a specialist medical doctor, also an endocrinologist. Dr. Ergin earned his medical degree with honors at Marmara University School of Medicine in Istanbul, Turkey. Then, he completed his internal medicine residency and endocrinology fellowship at Cleveland Clinic in Cleveland, Ohio. He is a board-certified physician in Internal Medicine and Endocrinology, diabetes, and metabolism. He is also a certified diabetes education specialist. Disclaimer: Any information on diseases and treatments available at this channel is intended for general guidance only and must never be considered a substitute for the advice provided by your doctor or other qualified healthcare professionals. Always seek the advice of your physician or other qualified healthcare professionals with questions you may have regarding your medical condition. #holisticmd #doctor #drergin #weightloss #weightlossjourney #loseweight #ozempic #mounjaro #wegovy #zepbound #loseweight #weightlosstips #howtoloseweight #health #healthyliving #healthychoices #healthy #healthyweightloss #sugarmd

Related Videos :

• WEIGHTLOSS Food That WOrks! How to lose weight & burn belly fat #weightloss #weightlossjourney [HDrWU5ZLb]
• Mounjaro, the New Weight Loss Drug on the Block [UGUmAOJtt]
• The Imperfections of Calorie Counting | What the Fitness | Biolayne [Da3zXIsjh]
• Axl Rose in court (Part 2/2) [al6blmP8H]
• Counting Clicks for Your OZEMPIC Injection - How to Get the Right Dosage Based on the Click Chart [iYXX2c1FF]